Cosmos Health Inc. (COSM) is a Healthcare · Medical Distribution company listed on NASDAQ. Price $0.32 (+7.26%), Market cap $0.02B, 52-week low–high $0.29 ~ $1.25.
Cosmos Health Inc. manufactures, develops, and trades branded nutraceutical products in Greece, the United Kingdom, Croatia, Bulgaria, the United Arab Emirates, Albania, North Macedonia, and Cyprus. The company provides prescription medications, over-the-counter drugs, medical devices, food supplements, nutraceuticals, cosmetics and other healthcare products under the Sky Premium Life and Mediterranation brand names. It offers ASTO-CHOL (Pravastatin), Diorium (Omeprazole), HEART-FREE (Clopidogrel), LIPICHOL (Atorvastatin), Miltus (Donepezil), Newzypra (Olanzapine), PNEUMO-KAST (Montelukast), Sahar (Pioglitazone), VIVALCID (Leucovorin), and Diabit-is (Sitagliptin). In addition, the company of
Financial statements, price targets, institutional (13F) holdings and related news for Cosmos Health Inc. are updated in real time on BlackAll Trade.
Cosmos Health Inc. trades at $0.32 (+7.26%). Real-time quotes and charts are available on BlackAll Trade.
Cosmos Health Inc. has a market cap of about $0.02B.
Cosmos Health Inc. manufactures, develops, and trades branded nutraceutical products in Greece, the United Kingdom, Croatia, Bulgaria, the United Arab Emirates, Albania, North Macedonia, and Cyprus. T